Vivozon Healthcare Inc (082800) - Total Assets
Based on the latest financial reports, Vivozon Healthcare Inc (082800) holds total assets worth ₩165.48 Billion KRW (≈ $112.14 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Vivozon Healthcare Inc shareholders equity for net asset value and shareholders' equity analysis.
Vivozon Healthcare Inc - Total Assets Trend (2009–2025)
This chart illustrates how Vivozon Healthcare Inc's total assets have evolved over time, based on quarterly financial data.
Vivozon Healthcare Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Vivozon Healthcare Inc's total assets of ₩165.48 Billion consist of 20.3% current assets and 79.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 1.9% |
| Accounts Receivable | ₩9.74 Billion | 5.9% |
| Inventory | ₩15.85 Billion | 9.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩18.40 Billion | 11.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2009–2025)
This chart illustrates how Vivozon Healthcare Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Vivozon Healthcare Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vivozon Healthcare Inc's current assets represent 20.3% of total assets in 2025, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2025, down from 18.7% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 10.0% in 2009.
- Asset Diversification: The largest asset category is intangible assets at 11.1% of total assets.
Vivozon Healthcare Inc Competitors by Total Assets
Key competitors of Vivozon Healthcare Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Theragen Etex Co.Ltd
KQ:066700
|
Korea | ₩245.25 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩87.88 Billion |
|
Huons Global Co. Ltd
KQ:084110
|
Korea | ₩1.47 Trillion |
Vivozon Healthcare Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.43 | 0.61 | 1.37 |
| Quick Ratio | 0.23 | 0.34 | 1.20 |
| Cash Ratio | 0.00 | 0.09 | 0.00 |
| Working Capital | ₩-44.17 Billion | ₩-27.80 Billion | ₩30.09 Billion |
Vivozon Healthcare Inc - Advanced Valuation Insights
This section examines the relationship between Vivozon Healthcare Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -10.3% |
| Total Assets | ₩165.48 Billion |
| Market Capitalization | $162.99 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vivozon Healthcare Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Vivozon Healthcare Inc's assets decreased by 10.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Vivozon Healthcare Inc (2009–2025)
The table below shows the annual total assets of Vivozon Healthcare Inc from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩165.48 Billion ≈ $112.14 Million |
-10.28% |
| 2024-12-31 | ₩184.45 Billion ≈ $125.00 Million |
+6.22% |
| 2023-12-31 | ₩173.65 Billion ≈ $117.68 Million |
-7.18% |
| 2022-12-31 | ₩187.07 Billion ≈ $126.78 Million |
-3.80% |
| 2021-12-31 | ₩194.47 Billion ≈ $131.79 Million |
-21.63% |
| 2020-12-31 | ₩248.16 Billion ≈ $168.17 Million |
+50.72% |
| 2019-12-31 | ₩164.65 Billion ≈ $111.58 Million |
+63.59% |
| 2018-12-31 | ₩100.65 Billion ≈ $68.21 Million |
+176.48% |
| 2017-12-31 | ₩36.40 Billion ≈ $24.67 Million |
-13.24% |
| 2016-12-31 | ₩41.96 Billion ≈ $28.44 Million |
-13.85% |
| 2015-12-31 | ₩48.71 Billion ≈ $33.01 Million |
-9.02% |
| 2014-12-31 | ₩53.54 Billion ≈ $36.28 Million |
-61.82% |
| 2010-12-31 | ₩140.22 Billion ≈ $95.02 Million |
+61.75% |
| 2009-12-31 | ₩86.69 Billion ≈ $58.75 Million |
-- |
About Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more